Pixium Vision is a bioelectronics and brain machine interface technology company that aims to create a world of bionic vision for individuals who have lost their sight. Their mission is to provide best-in-class bionic vision restoration systems, empowering the blind to regain greater autonomy and quality of daily living. One of Pixium Vision's innovative products is the Prima System, which consists of a miniaturized and wireless sub-retinal PRIMA implant, a pocket computer with breakthrough algorithms, and a pair of glasses that captures the visual scene.

This cutting-edge system allows individuals with severe vision loss caused by the dry atrophic form of Age-related Macular Degeneration (AMD) to regain partial visual perception. Pixium Vision obtained exclusive rights to the patented technology for the Prima System from Stanford University. Currently, the company is conducting feasibility clinical trials in France and the United States for patients with retinal degeneration, as there is currently no treatment available for this condition.

Through their innovative technology, Pixium Vision strives to improve the lives of those affected by vision loss, offering them new possibilities and a brighter future